OYST - Oyster Point Pharma Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript
Oyster Point Pharma, Inc. (OYST) Q4 2021 Earnings Conference Call February 24, 2022 16:30 ET Company Participants Daniel Lochner - Chief Financial Officer Jeffrey Nau - President and Chief Executive Officer John Snisarenko - Chief Commercial Officer Conference Call Participants Ken Cacciatore - Cowen Joe Catanzaro - Piper Sandler Patrick Dolezal - LifeSci Capital Chris Neyor - JPMorgan Presentation Operator Good evening and welcome to Oyster Point Pharma’s Fourth Quarter 2021 Earnings Conference Call. My name is Valerie and I will be your operator today. [Operator Instructions] At this time, I’d like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma’s Chief Financial Officer. Please go ahead. Daniel Lochner Good evening, everyone and welcome to Oyster Point Pharma’s fourth quarter earnings conference call for the 3 months ended December 31, 2021. This evening, we issued a press release containing our fourth quarter and full year ended December
For further details see:
Oyster Point Pharma, Inc. (OYST) CEO Jeffrey Nau on Q4 2021 Results - Earnings Call Transcript